STOCK TITAN

4Front Ventures Corp Stock Price, News & Analysis

FFNTF OTC

Welcome to our dedicated page for 4Front Ventures news (Ticker: FFNTF), a resource for investors and traders seeking the latest updates and insights on 4Front Ventures stock.

News about 4Front Ventures Corp. (FFNTF) centers on its role as a vertically integrated multi-state cannabis operator and on significant legal and financial developments affecting the company. 4Front reports operations in Illinois and Massachusetts and facilities in Washington, with activities spanning cultivation, production, wholesale, and retail through its Mission-branded dispensaries and other outlets.

Recent news has focused on governance changes, financial reporting delays, and formal restructuring processes. The company has issued updates on delayed audited annual financial statements and related disclosures, applications for a management cease trade order, and the subsequent failure-to-file cease trade order issued by the Ontario Securities Commission. These items are important for readers tracking regulatory compliance and trading restrictions on the company’s securities.

Coverage also includes 4Front’s announcements that all of its U.S. subsidiaries filed for voluntary receivership in aid of liquidation under Massachusetts law and that a court-appointed Receiver has been authorized to operate, manage, and pursue the sale of those subsidiaries and their assets. Additional news has described the company’s assignment into bankruptcy under the Canadian Bankruptcy and Insolvency Act and the appointment of a trustee in those proceedings.

Alongside these restructuring developments, earlier releases have highlighted operational updates such as the official ribbon cutting of a large cultivation and production facility in Matteson, Illinois, and commentary on wholesale and retail performance in Illinois, Massachusetts, and Washington. Readers following FFNTF news can use this page to review the sequence of corporate, regulatory, and operational announcements that shape the company’s current situation.

Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) has announced the closing of the first phase of a multiphase expansion project in Matteson, Illinois. The project will create a 250,000 sq. ft. cultivation and production facility, backed by Innovative Industrial Properties. The facility aims to generate over 500 jobs and meet the growing demand in Illinois's cannabis market. Expected to be completed by Q4 2022, this initiative marks a major step in establishing the largest cannabis cultivation site in the state, set to produce various cannabis products for consumers and partner dispensaries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF), a multi-state cannabis operator, will report its second quarter financial results for the period ended June 30, 2021, on August 16, 2021, after market close. A conference call will be held at 5:00 p.m. ET for discussing the results and current business trends. Investors can join the call via dial-in or webcast. Since 2011, 4Front has established itself in the cannabis market with over 20 brands and nearly 2,000 products, focusing on delivering value and integrating operations across medical and adult-use markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
conferences earnings
-
Rhea-AI Summary

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) announced the immediate resignation of Co-Founder and President of Mission Dispensaries, Kris Krane, after nearly 11 years. Krane will transition to a strategic advisor role. 4Front has no immediate plans to replace him. CEO Leo Gontmakher praised Krane's contributions to the cannabis industry and expressed gratitude for his leadership. 4Front continues to operate in key cannabis markets, emphasizing its commitment to quality and value-driven products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.69%
Tags
management
Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) has launched its award-winning Terp Stix™ in Illinois, available in one-gram singles for $25 at the Mission Dispensaries in South Chicago and Calumet City. The product leverages proprietary infusion technology for a smooth consumption experience. Following significant pre-roll sales growth, 4Front aims to capture the Illinois market with affordable, high-quality pre-rolls tailored to consumer preferences. The company plans to expand Terp Stix™ availability to additional dispensaries across Illinois in the coming months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.36%
Tags
none
-
Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) has announced a $75,000 donation to Elk Grove Village, Illinois, aimed at enhancing community health and wellness programs. This contribution includes $30,000 for local community events and outreach, and $15,000 each for the Elk Grove Village Cares Program, the Police Drug Education Program, and the Kenneth Young Youth Center. The donation aligns with 4Front's development agreement for its cultivation and manufacturing facility in Elk Grove Village, emphasizing its commitment to community service and public health initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
none
-
Rhea-AI Summary

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) announced its executive team's participation in two major conferences on June 3-4, 2021. The Piper Sandler 41st Annual Consumer Marketplace Conference will feature small group and one-on-one investor meetings. Additionally, Andrew Thut, Chief Investment Officer, will engage in a fireside chat during the Benzinga Cannabis Capital Conference on June 4, 2021, at 4:15 p.m. ET. 4Front, a multi-state cannabis operator, offers over 25 cannabis brands and operates in several states including Illinois and California.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.09%
Tags
conferences
Rhea-AI Summary

4Front Ventures Corp. reported a Q1 2021 Systemwide Pro Forma Revenue of $31.4 million, a 26% increase from Q4 2020. The adjusted EBITDA was $5.9 million, with a margin of 19%. The company reiterated its FY2021 guidance, anticipating $170-$180 million in revenue and $40-$50 million in adjusted EBITDA. Long-term projections suggest potential revenue of $650 million and EBITDA of $250 million from existing licensed projects. Operational expansions are underway in California, Massachusetts, and Illinois, with a new facility set to open in Q2 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
-
Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) announced that the Brookline Select Board has unanimously approved its Mission Brookline adult-use dispensary in Massachusetts. The Town of Brookline has granted the dispensary's Certificate of Occupancy, allowing it to move forward. Once the Massachusetts Cannabis Control Commission gives final approval, the location will serve adults 21 and over, initially offering online appointment pickups. 4Front plans to provide a diverse range of cannabis products and is currently hiring staff for the new location.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
none
-
Rhea-AI Summary

4Front Ventures Corp. (CSE: FFNT; OTCQX: FFNTF) will report its first quarter financial results on May 24, 2021, after market close. The update will be discussed in a conference call at 5:00 p.m. ET. 4Front, a multi-state cannabis operator, offers over 25 brands, including Marmas and Crystal Clear, across key states like Illinois and Massachusetts. The call can be accessed by dialing specific numbers, and it will be available for replay until May 31, 2021. For further updates, interested parties can sign up for their newsletter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
conferences earnings
Rhea-AI Summary

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) will participate in the Canaccord Genuity Virtual Cannabis Conference on May 11, 2021. Andrew Thut, the Chief Investment Officer, will join a panel discussion at 12:00 p.m. ET. The company is a national multi-state cannabis operator known for mass-produced, low-cost quality branded cannabis products, including over 25 brands such as Marmas and Crystal Clear. 4Front operates across several states including Illinois, Massachusetts, and California.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
none

FAQ

What is the current stock price of 4Front Ventures (FFNTF)?

The current stock price of 4Front Ventures (FFNTF) is $0.000001 as of January 2, 2026.

What is the market cap of 4Front Ventures (FFNTF)?

The market cap of 4Front Ventures (FFNTF) is approximately 3.3M.
4Front Ventures Corp

OTC:FFNTF

FFNTF Rankings

FFNTF Stock Data

3.30M
448.45M
51.06%
6.72%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Phoenix

FFNTF RSS Feed